AGGARWAL GAURAV reported 1 transaction at UNICYCIVE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/26/2025ACC: 0001213900-25-080808
Director
Since Mar 2023
+649.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
652.90K acquired · 3.20K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+652.90K
Price / share
—
Trade value
—
% of position
57.4%
8/25/2025
1.14M→1.79M
Total
Net shares
+652.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/25/2025 | C · Conversion | +652.90K | — | — | 57.4% | 1.14M | 1.79M |
| Total | +652.90K | $0.00 | ||||||
Derivative Transactions1
Series A-2 Prime Preferred Stock
Indirect
Converts to
Common Stock
652.90K shares
Shares
−3.20K
Strike price
4.90
Held after
0.00
Exercisable
—
8/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 Prime Preferred Stock Indirect | Common Stock652.90K shares | 8/25/2025 | D · Disposition | −3.20K | 4.90 | — | 0.00 |